Search
Search Results
##search.searchResults.foundPlural##
-
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2544PDF: 870HTML: 2122 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3368PDF: 1280HTML: 2215Fi.1 Gritti.Rambaldi: 205 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1390PDF: 819HTML: 3123 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
1982PDF: 896HTML: 1865 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2853PDF: 1436HTML: 3045Cover Letter: 207 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2451HTML: 271PDF: 868 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6312PDF: 2112HTML: 14015Untitled: 199figure: 184 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
1783PDF: 835HTML: 1149Cover: 182 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
940PDF: 573HTML: 2193Cover Letter: 190 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3034PDF: 1024HTML: 3078 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4300PDF: 1372HTML: 2039 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1773PDF: 938HTML: 1111Untitled: 152Untitled: 170Untitled: 157Untitled: 158 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2218PDF: 964HTML: 1897 -
-
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1928PDF: 1099HTML: 1892Lung computed tomography CT scan image: 201 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10597PDF: 6352HTML: 21785 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2280PDF: 1821HTML: 144 -
-
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1184PDF: 783HTML: 218 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4756PDF: 2836HTML: 2284 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1064PDF: 1065HTML: 442 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2491PDF: 922HTML: 530 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1362PDF: 528HTML: 197 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1602PDF: 798HTML: 1232Figure 1: 172Figure 2: 188Figure 3: 183 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1043PDF: 1154Suppl. Files: 569HTML: 88 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7442PDF: 2421HTML: 1733Table 1.: 208Table 2.: 217Table 3.: 201Table 4.: 200 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3679PDF: 1283HTML: 728Figure 2: 452Figure 1: 3117 -
-
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1823PDF: 798HTML: 3600 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1462PDF: 1058HTML: 216 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7840PDF: 719HTML: 214 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2412PDF: 923HTML: 529







